FEDERAL TRADE COMMISSION v. CEPHALON, INC., No. 2:2008cv02141 - Document 267 (E.D. Pa. 2014)

Court Description: MEMORANDUM AND ORDER THAT DIRECT PURCHASERS MOTION IS GRANTED IN PART AS OUTLINED IN THE OPINION. THE END PAYORS MOTION IS GRANTED IN PART AS OUTLINED IN THE OPNION. APOTEX'S MOTION IS GRANTED IN PART, AS OUTLINED IN THE OPINION. THE MONOPOLY POWER PORTION OF APOTEX'S MOTION WILL BE RESOLVED SEPARATELY.. SIGNED BY HONORABLE MITCHELL S. GOLDBERG ON 3/13/14. 3/13/14 ENTERED AND COPIES MAILED, E-MAILED.(rf, )

Download PDF
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA ______________________________________________________________________________ : KING DRUG COMPANY OF FLORENCE, INC., : CIVIL ACTION et al., : Plaintiffs, : : v. : No. 2:06-cv-1797 : CEPHALON, INC., et al., : Defendants. : _________________________________________ :__________________________________ : VISTA HEALTHPLAN, INC., et al., : CIVIL ACTION Plaintiffs, : : v. : No. 2:06-cv-1833 : CEPHALON, INC., et al., : Defendants. : _________________________________________ :__________________________________ : APOTEX, INC., : CIVIL ACTION Plaintiff, : : v. : No. 2:06-cv-2768 : CEPHALON, INC., et al., : Defendants. : _________________________________________ :___________________________________ : FEDERAL TRADE COMMISSION, : CIVIL ACTION Plaintiff, : : v. : No. 2:08-cv-2141 : CEPHALON, INC., : Defendant. : _________________________________________ :__________________________________ ORDER AND NOW, this 13th day of March, 2014, upon consideration of the Direct Purchaser Class Plaintiffs Motion for Partial Summary Judgment on the Patent Issues (06-1797, doc. no. 518), the End Payor Class Plaintiffs Motion for Partial Summary Judgment (06-1833, doc. no. 233), and Apotex s Motion for Partial Summary Judgment as to Antitrust Liability and Monopoly Power (06-2768, doc. no. 601), Cephalon and the Generic Defendants responses thereto, and the replies, and for the reasons detailed in the accompanying Memorandum Opinion, it is hereby ORDERED that: ï ­ The Direct Purchasers motion is GRANTED IN PART, as outlined in the opinion. ï ­ The End Payors motion is GRANTED IN PART, as outlined in the opinion. ï ­ Apotex s motion is GRANTED IN PART, as outlined in the opinion. The monopoly power portion of Apotex s motion will be resolved separately. BY THE COURT: /s/ Mitchell S. Goldberg ______________________________ Mitchell S. Goldberg, J.

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.